Investorideas.com

Get investor ideas from our AI, cannabis, cleantech, crypto, gaming, mining, sports podcasts - be a guest or sponsor: call 800 665 0411


Share on StockTwits

Investor Ideas Potcasts #543, Cannabis News and Stocks on the Move (OTC: OWPC) (TSXV: KHRN) (OTCQX: KHRNF), (TSXV: HITI) (OTCQB: HITIF), (TSX: CLIQ)

 

Delta, Kelowna, BC - March 22, 2021 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2021/032221-StocksToWatch.mp3

Investor Ideas Potcasts #543, Cannabis News and Stocks on the Move (OTC: OWPC) (TSXV: KHRN) (OTCQX: KHRNF), (TSXV: HITI) (OTCQB: HITIF), (TSX: CLIQ)

SHARE PODCAST:      

Hear Investor ideas cannabis potcast on iTunes

Hear the investor ideas potcast on Spotify

Today's podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today's podcast we look at a few public company announcements.

One World Pharma Inc. (OTC: OWPC) a U.S. based, fully licensed, pure-play hemp and cannabis ingredient producer in Colombia, is encouraged by a formal recommendation to allow for the international export of dry cannabis flower. In a recently published letter from the Colombian Ministry of Health and Social Protection to the President of Colombia, related to Law 1787 and Decree 613, the Ministry calls for modifications that would allow for the exportation of dry flower.

One World Pharma believes the freedom to sell its dry flower internationally would be of enormous benefit to the Company and the entire industry in Colombia and would significantly increase the Company's ingredient product offerings in scale, and reduce time to market.  Dry flower represents over 50% of the demand in many markets such as the United States, Germany and Australia. Currently, such sales are not allowed.

One World Pharma, through its strategic relationships with small farmers, indigenous groups, FEDECORE, and the Colombian Federation of Regional Advisors, has access to significant acreage for cultivation. Given One World Pharma's operational strengths, the modifications to Colombia's laws would make it possible to go from seed to sale within 120 days.

The Company continues to increase its production capacity at its initial farm in Popayan and is currently negotiating contracts that would provide it with its own extraction capabilities.

"Permission to export our flower would indeed be a milestone for One World Pharma," said Isiah Thomas, CEO of One World Pharma. "We are well-positioned to act on this excellent opportunity with the relationships, technology and genetics to grow the finest flower at scale and leveraging the tremendous equatorial advantages provided by Colombia. This would be a great complement to our existing efforts to sell high quality extracted products under existing law."

Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated cannabis leader with core operations in Latin America and Europe, announced that the Company has successfully delivered EU-GMP medical cannabis product to Germany. In collaboration with Nimbus Health, a leading medical cannabis distributor in Germany, Khiron is now positioned for imminent first sales in Germany. Khiron products are currently in inventory in the Nimbus warehouse, ready to be prescribed to patients and distributed through a vast network of 300 pharmacies across Germany.

This major milestone represents a new revenue stream for the Company and positions Khiron's European team to execute on its German medical strategy. Leveraging its partner's large distribution network and Khiron's ongoing investments in physician education, the Company has secured immediate access to the German market. Khiron 1/14 will focus on indications such as anxiety, substance use disorder, and migraines, addressing patient needs and improving access to medical cannabis.

Tejinder Virk, President of Khiron Europe, commented, "Since signing our distribution agreement with Nimbus Health in 2020, the Company's European Sales and Marketing teams have been actively educating doctors and raising awareness for our products. We are excited to launch our portfolio with Khiron 1/14, a product that covers unmet medical need in the German market. As we continue to expand our presence in the UK and Germany, we will leverage our clinical expertise from Colombia to provide the EU market with additional cannabis-based medicinal products."

Franziska Katterbach, Managing Director & Chief Legal Officer for Khiron Europe based in Frankfurt, commented, "I would like to thank our European team for their unwavering perseverance over the past few months; their efforts have allowed us to achieve this significant milestone despite the challenges of the global pandemic and Germany's strict regulatory environment. With all permits in place and product now available for sale, we look forward to increasing our presence in this growing market with over 60,000 medical cannabis patients and a population of over 82 million people. We are already developing additional cannabis-based medicinal products from our certified strains recently imported from Colombia to improve access and product selection for German patients."

Through its EU-GMP certified supply chain partners in Europe, Khiron continues to expand its offering of world-class medical cannabis products, targeting the introduction of cannabis-based medicinal products based on those already distributed by the Company in Colombia and Peru. With Khiron's proof of concept now validated in Colombia, the Company plans to leverage its clinical data and IP, educational platforms, and technology and systems to expand into new markets.

High Tide Inc. (TSXV: HITI) (OTCQB: HITIF), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of smoking accessories, announced that it has filed a Form 40-F Registration Statement with the United States Securities and Exchange Commission, fulfilling a significant milestone in the process for High Tide to list its common shares on The Nasdaq Stock Market LLC. A copy of the Form 40-F is available on the Company's website at www.hightideinc.com.

"We were the first Canadian cannabis retailer to pursue this prestigious listing on Nasdaq and we believe it will allow us to greatly expand our shareholder base, enhance shareholder value and accelerate our already aggressive M&A initiatives in Canada, Europe and the United States," said Raj Grover, President and Chief Executive Officer of High Tide. "We are currently in several discussions with potential acquisition targets in these jurisdictions and look forward to updating the market soon," added Mr. Grover.

The listing of the Company's common shares on Nasdaq remains subject to the approval of Nasdaq and the satisfaction of all applicable listing and regulatory requirements, including the effectiveness of the Form 40-F.

High Tide's common shares will continue to trade on the OTCQB under the ticker symbol HITIF until Nasdaq approval and up listing. High Tide's common shares will continue to trade on the TSX Venture Exchange under the ticker symbol "HITI" post-Nasdaq up listing. There can be no assurance, however, that Nasdaq approval will be received.

Following receipt of all required approvals, the Company will issue a press release announcing its first trading date on Nasdaq.

The Company will also release its financial and operational results for the quarter ended January 31, 2021 after market close on April 1, 2021. High Tide's first quarter 2021 financial and operational results will be available on SEDAR and on the Company's website at www.hightideinc.com/invest.

Following the release of its first quarter 2021 financial and operational results, High Tide will host a conference call with Raj Grover, President and Chief Executive Officer, and Rahim Kanji, Chief Financial Officer, at 5:00 PM Eastern Time on April 1, 2021. The conference call will discuss High Tide's first quarter 2021 financial and operational results and updates on the Company's plans for 2021.

Alcanna Inc. (TSX: CLIQ) and YSS Corp. (TSX-V: YSS) announced the completion of their business combination previously announced on January 18, 2021, which resulted in a reverse take-over of YSS pursuant to the policies of the TSX Venture Exchange and a name change of YSS to "Nova Cannabis Inc.". The common shares of Nova are expected to begin trading on the TSXV under the ticker symbol "NOVC" on or about March 24, 2021.

Immediately upon completion of the Transaction, Nova will have 53 cannabis retail locations in Alberta, Saskatchewan and Ontario. These cannabis retail locations range in size from 1,200 to 5,600 square feet and are operated under the "Nova Cannabis", "Deep Discount Cannabis", "Value Buds", "YSS", and "Sweet Tree" brands. Nova has more than 20 additional cannabis retail locations in development for 2021. The majority of Nova's cannabis retail locations (including locations previously operated by YSS) are expected to be re-branded as "Value Buds" and will target the value-conscious consumer, an under-served segment of the market that is estimated to account for approximately 70% of total recreational cannabis market in Canada (both legal and illicit).

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and that this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment.

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

Investors can trade these stocks and other ideas on our site using our list of top stock trading apps including Robinhood , Acorn, Stash and others.

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

The Investorideas.com podcasts are also available on iTunes (Apple Podcasts), Audible, Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio, Google Play Music and most audio platforms available.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/

Download our Mobile App for iPhone and Android

Contact Investorideas.com

800-665-0411


Get more Cannabis Stock Investor Ideas - news, articles, podcasts and stock directories

Buy a cannabis guest post on Investorideas.com